Conflict and kala-azar: Determinants of adverse outcomes of kala-azar among patients in southern Sudan

Clinical Infectious Diseases

Volumn 38, Issue 5, 2004, Pages 612-619

  Collin, Simon ^a   Davidson, Robert ^b   Ritmeijer, Koert ^c   Keus, Kees ^c   Melaku, Yosef ^c   Kipngetich, Sammy ^c   Davies, Clive ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b NORTHWICK PARK HOSPITAL   (United Kingdom)

^c MÉDECINS SANS FRONTIÈRES   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; HEMOGLOBIN; PAROMOMYCIN; STIBOGLUCONATE SODIUM; ANTIMONY GLUCONATE;

ADOLESCENT; ADULT; ANEMIA; ARTICLE; BLEEDING; BODY MASS; DEATH; DIARRHEA; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEIGHT; HUMAN; LEISHMANIASIS; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; PRIORITY JOURNAL; RISK FACTOR; SKIN LEISHMANIASIS; SPLENOMEGALY; SUDAN; SURVIVAL; VOMITING; WEIGHT; AGE; ANIMAL; BODY WEIGHT; CHILD; METABOLISM; PRESCHOOL CHILD; RECURRENT DISEASE; TREATMENT OUTCOME; VISCERAL LEISHMANIASIS; WAR;

ADOLESCENT; AGE FACTORS; ANIMALS; ANTIMONY SODIUM GLUCONATE; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LEISHMANIASIS, VISCERAL; MALE; RECURRENCE; RISK FACTORS; SUDAN; TREATMENT OUTCOME; WAR;

EID: 1442302894     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/381203     Document Type: Article

References (14)

1. Schorscher JA, Goris M. Incrimination of Phlebotomus (Larroussius) orientalis as a vector of visceral leishmaniasis in western Upper Nile province, southern Sudan. Trans R Soc Trop Med Hyg 1992; 86:622-3.
2. Zijlstra EE, el-Hassan AM. Leishmaniasis in Sudan. Trans Roy Soc Trop Med Hyg 2001; 95(Suppl 1):S1-76.
3. Seaman J, Mercer AJ, Sondorp E. The epidemic of visceral leishmaniasis in western Upper Nile, southern Sudan: course and impact from 1984 to 1994. Int J Epidemiol 1996; 25:862-71.
4. Seaman J, Ashford RW, Schorscher J, Dereure J. Visceral leishmaniasis in southern Sudan: status of healthy villagers in epidemic conditions. Ann Trop Med Parasitol 1992; 86:481-6.
5. Seaman J, Mercer AJ, Sondorp HE, Herwaldt BL. Epidemic visceral leishmaniasis in southern Sudan: treatment of severely debilitated patients under wartime conditions and with limited resources. Ann Intern Med 1996; 124:664-72.
6. Médecins Sans Frontières (MSF). Violence, health and access to aid in Unity State/Western Upper Nile, Sudan. Amsterdam: MSF, 2002.
7. Seaman J, Pryce D, Sondorp HE, Moody A, Bryceson AD, Davidson RN. Epidemic visceral leishmaniasis in Sudan: a randomized trial of aminosidine plus sodium stiboglucanate versus sodium stiboglucanate alone. J Infect Dis 1993; 168:715-20.
8. Griekspoor A, Sondorp E, Vos T. Cost-effectiveness anaylsis of humanitarian relief interventions: visceral leishmaniasis treatment in the Sudan. Health Policy Plan 1999; 14:70-6.
9. World Health Organization (WHO). Manual on visceral leishmaniasis control. Geneva: WHO, 1996.
10. Médecins Sans Frontières (MSF). Manual for the diagnosis and treatment of visceral leishmaniasis under field conditions. Amsterdam: MSF, 1999.
11. Zijlstra EE, Musa AM, Khalil EA, el-Hassan IM, el-Hassan AM. Post-kala-azar dermal leishmaniasis. Lancet Infect Dis 2003; 3:87-98.
12. Hackett L. Spleen measurement in malaria. J Nat Malaria 1944; 3:121-3.
13. Sundar S, More DK, Singh MK, et al. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis 2000; 31:1104-7.
14. Lyons S, Veeken H, Long J. Visceral leishmaniasis and HIV in Tigray, Ethiopia. Trop Med Int Health 2003; 8:733-9.